| 1 |
30744151 | A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis. | 2019 Feb 10 |
1 |
| 2 |
30962288 | Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells. | 2019 Jun |
2 |
| 3 |
27634953 | Influence of CYP2C19 genetic polymorphisms on clinical outcomes of intracranial aneurysms treated with stent-assisted coiling. | 2017 Oct |
1 |
| 4 |
26265611 | CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome. | 2015 Aug 20 |
1 |
| 5 |
23413279 | The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors. | 2013 Jun |
1 |
| 6 |
20549497 | Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients. | 2010 Oct |
1 |
| 7 |
20669013 | Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism. | 2010 Nov |
1 |
| 8 |
17623107 | Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals. | 2007 Jul 11 |
1 |
| 9 |
16384813 | Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. | 2006 Jan-Feb |
1 |
| 10 |
15639978 | [Cytochrome P450 2C19 gene polymorphism in 104 Chinese Zang volunteers]. | 2004 Mar |
1 |
| 11 |
15651900 | Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups. | 2004 |
1 |
| 12 |
12480299 | Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. | 2003 Feb |
2 |
| 13 |
11678778 | Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. | 2001 Oct |
1 |
| 14 |
8807668 | Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese. | 1996 Jun |
1 |
| 15 |
8835703 | Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients. | 1996 Aug |
1 |